Broad betacoronavirus neutralization by a stem helix–specific human antibody

Author:

Pinto Dora1,Sauer Maximilian M.2ORCID,Czudnochowski Nadine3ORCID,Low Jun Siong4ORCID,Tortorici M. Alejandra2ORCID,Housley Michael P.3,Noack Julia3ORCID,Walls Alexandra C.2ORCID,Bowen John E.2ORCID,Guarino Barbara1ORCID,Rosen Laura E.3ORCID,di Iulio Julia3ORCID,Jerak Josipa4ORCID,Kaiser Hannah3ORCID,Islam Saiful3,Jaconi Stefano1,Sprugasci Nicole1ORCID,Culap Katja1ORCID,Abdelnabi Rana5ORCID,Foo Caroline5ORCID,Coelmont Lotte5ORCID,Bartha Istvan1ORCID,Bianchi Siro1ORCID,Silacci-Fregni Chiara1,Bassi Jessica1ORCID,Marzi Roberta1ORCID,Vetti Eneida1,Cassotta Antonino4ORCID,Ceschi Alessandro6789ORCID,Ferrari Paolo91011ORCID,Cippà Pietro E.1012,Giannini Olivier910ORCID,Ceruti Samuele13ORCID,Garzoni Christian14ORCID,Riva Agostino15ORCID,Benigni Fabio1ORCID,Cameroni Elisabetta1,Piccoli Luca1,Pizzuto Matteo S.1,Smithey Megan3,Hong David3,Telenti Amalio3,Lempp Florian A.3,Neyts Johan5,Havenar-Daughton Colin3,Lanzavecchia Antonio1,Sallusto Federica416,Snell Gyorgy3,Virgin Herbert W.31718,Beltramello Martina1,Corti Davide1,Veesler David2

Affiliation:

1. Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

2. Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

3. Vir Biotechnology, San Francisco, CA 94158, USA.

4. Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.

5. Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, 3000 Leuven, Belgium.

6. Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.

7. Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.

8. Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.

9. Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland.

10. Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.

11. Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia.

12. Faculty of Medicine, University of Zurich, 8057 Zurich, Switzerland.

13. Intensive Care Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.

14. Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.

15. III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.

16. Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland.

17. UT Southwestern Medical Center, Dallas, TX 75390, USA.

18. Washington University School of Medicine, St. Louis, MO 63110, USA.

Abstract

Targeting a range of betacoranaviruses In the past 20 years, three highly pathogenic β-coronaviruses have crossed from animals to humans, including the most recent: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A spike protein that decorates these viruses has an S1 domain that binds host cell receptors and an S2 domain that fuses the viral and cell membranes to allow cell entry. The S1 domain is the target of many neutralizing antibodies but is more genetically variable than S2, and antibodies can exert selective pressure, leading to resistant variants. Pinto et al . identified five monoclonal antibodies that interact with a helix in the S2 domain. The most broadly neutralizing antibody inhibited all β-coronavirus subgenera and reduced viral burden in hamsters infected with SARS-CoV-2. —VV

Funder

National Institutes of Health

U.S. Department of Energy

National Institute of General Medical Sciences

National Institute of Allergy and Infectious Diseases

GlaxoSmithKline foundation

Swiss National Science Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 305 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3